Group: Hypromellose
Also known as: Hydroxypropylmethylcellulose, Hydroxypropyl Methyl Cellulose, Hydroxypropyl Methylcellulose, Hypromellose
Group: Hypromellose
Hydroxypropyl Methylcellulose (HPMC), also known as Hypromellose, is a semisynthetic, inert, viscoelastic polymer used extensively as a thickening agent and emulsifier in food products as well as in the manufacturing of supplements and medications.
Group: Lactose
UNII Code: J2B2A4N98G
Group: Saccharomyces boulardii
Daily Probiotic Supplement
Unique strain with larger, stronger cells than other probiotics
Saccharomyces boulardii lyo CNCM- 1-745
Supports a immune response Strengthen digestive balance Complements your active lifestyle
Do not refrigerate.
Keep out of reach of children.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
100% titanium dioxide free clear capsules
100% titanium dioxide free clear capsules
Gluten-free
Vegetarian
Non-GMO
For men and women
Suggested use: 2 capsules 1-2 times daily
Appropriate for lactose intolerance Be Biotic bi-ot-ic,/bi atik/ Adjective Proactive about health Driven, confident, and strong
Biocodex|USA
I strive to be healthy and push myself to hike new heights every day... I am Biotic
1. Swidsinski A, Loening-Baucke V, Verstraelen H, Osowska S, Doerffel Y (2008) Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea. Gastroenterology: 135(2):568-579. 2. Martins FS, Silva AA, Vieira AT, Barbosa FH, Arantes RM, et al. (2009) Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties. Arch Microbiol 191:623-630. 3. Klein SM, Elmer GW, McFarland LV, Surawicz CM, Levy RH (1993) Recovery and elimination of the biotherapeutic agent, Saccharomyces boulardii, in healthy human volunteers. Pharm Res 10:1615-1619. 4. Schneider SM, Girard-Pipau F, Filippi J, Hebuterne X, Moyse D, et al. (2005) Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition. World J Gastroenterol 11:6165-6169. 5. Buts JP, Bernasconi P, Van Craynest MP, Maldague P, De Meyer R (1986) Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii. Pediatr Res 20:192-196.
If you notice any false or inaccurate information in our product listings, please contact us so we can correct it.
Discover more products from our collection
